Hlib Chabaniuk

Pacific Biosciences of California unveils webinar on long-read multiomics breakthrough in human disease research

Pacific Biosciences of California unveils webinar on long-read multiomics breakthrough in human disease research
Multiomics in disease research

Pacific Biosciences of California is hosting a webinar to explore how long-read multiomics is transforming human disease research.

The event will address how leading scientists are combining genomic, epigenomic, and proteomic data to drive progress in rare disease understanding, neurodegeneration studies, and AI-powered drug discovery. The company aims to highlight innovation at the intersection of multiomics and healthcare, supporting the next wave of research and therapeutic development.

Earlier this year, Pacific Biosciences of California propelled T2T genomics as the journal Cell published a special issue featuring 13 new complete genome assemblies here. The company has also analyzed Illumina TruPath against PacBio HiFi whole genome sequencing, focusing on benchmarking, variant calling, and phasing here. These efforts highlight Pacific Biosciences’ continued activity in genomic technology development.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.